α-Synuclein, leucine-rich repeat kinase-2, and manganese in the pathogenesis of Parkinson disease
about
Potential Role of Epigenetic Mechanism in Manganese Induced NeurotoxicityInteraction of divalent cations with peptide fragments from Parkinson's disease genes.Mn(II) and Zn(II) interactions with peptide fragments from Parkinson's disease genes.ATP13A2 (PARK9) polymorphisms influence the neurotoxic effects of manganeseExpression and Transport of α-Synuclein at the Blood-Cerebrospinal Fluid Barrier and Effects of Manganese ExposureAn update on the diagnosis and treatment of Parkinson diseaseBrain disposition of α-Synuclein: roles of brain barrier systems and implications for Parkinson's disease.The Ca2+/Mn2+ ion-pump PMR1 links elevation of cytosolic Ca(2+) levels to α-synuclein toxicity in Parkinson's disease models.Role of manganese in neurodegenerative diseases.Leucine-rich repeat kinase 2 inhibitors: a review of recent patents (2011 - 2013).The Central Role of Biometals Maintains Oxidative Balance in the Context of Metabolic and Neurodegenerative Disorders.Protective effects of flavonol isoquercitrin, against 6-hydroxy dopamine (6-OHDA)-induced toxicity in PC12 cellsElevated potassium provides an ionic mechanism for deep brain stimulation in the hemiparkinsonian rat.Clinical effects of chemical exposures on mitochondrial function.Mitochondria: A Common Target for Genetic Mutations and Environmental Toxicants in Parkinson's Disease.
P2860
Q26744563-E7458FCB-8E1E-4699-B53A-2E0BAA8B1A7EQ27930795-9D72D207-EFC0-45A8-90C9-59F32D97E0AEQ27932738-86451196-54CD-448A-A594-4727FFABEEEEQ28118761-52A52DEC-7643-45C9-9A40-DAC817D0FD82Q28395564-04998B45-8C1F-44A6-AC1B-295DF2ADCE4EQ30243899-FC9ED36B-A994-4C39-A162-F7F6C1826965Q33997655-2A751EF9-D5FD-433F-BE5F-AFEC5FA52648Q36603128-0B0C4C1E-C26A-4677-BF1F-FE48E29C9012Q37941268-0D145631-8DF4-46EF-85A8-8B9B805DB8F2Q38219430-E403BEF9-7E76-46AC-AB57-B81215B1E661Q41023080-AE8F73F3-4331-4019-8AA2-3A7CE48FCFEFQ41906540-C9479F44-2CA4-4E2F-ABF6-01CAC75FDD91Q45981012-B5C2DD3B-06A7-4264-9A28-1BD216BDD25AQ46328664-0F876548-A689-4DFB-A3E7-775968BFD87EQ47147993-BD12B6E6-5A74-4EDF-A777-6478F425C370
P2860
α-Synuclein, leucine-rich repeat kinase-2, and manganese in the pathogenesis of Parkinson disease
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
α-Synuclein, leucine-rich repe ...... hogenesis of Parkinson disease
@ast
α-Synuclein, leucine-rich repe ...... hogenesis of Parkinson disease
@en
type
label
α-Synuclein, leucine-rich repe ...... hogenesis of Parkinson disease
@ast
α-Synuclein, leucine-rich repe ...... hogenesis of Parkinson disease
@en
prefLabel
α-Synuclein, leucine-rich repe ...... hogenesis of Parkinson disease
@ast
α-Synuclein, leucine-rich repe ...... hogenesis of Parkinson disease
@en
P2860
P1433
P1476
α-Synuclein, leucine-rich repe ...... hogenesis of Parkinson disease
@en
P2093
Benoit I Giasson
Jason P Covy
P2860
P304
P356
10.1016/J.NEURO.2011.01.003
P577
2011-01-14T00:00:00Z